Silo Pharma, Inc.
SILONASDAQHealthcare● Active
$6.20
+$0.30(+5.00%)
Market Cap$5604505
P/E Ratio—
52W High$15.15
52W Low$3.315
Silo Pharma, Inc.（SILO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SILO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.07M | $0.07M | $0.07M | $0.07M | $0.07M |
| Cost of Revenue | $0.89M | $0.01M | $0.01M | $0.01M | $0.01M |
| Gross Profit | ($0.81M) | $0.07M | $0.07M | $0.07M | $0.07M |
| Gross Margin %(computed) | — | 91.90% | 91.90% | 91.90% | 92.98% |
| Operating Expenses | |||||
| R&D Expenses | $2.16M | $2.37M | $0.85M | $1.29M | $0.69M |
| G&A Expenses | $2.15M | $2.40M | $3.08M | $2.43M | $2.27M |
| Total Operating Expenses | $3.47M | $4.77M | $3.92M | $3.69M | $2.81M |
| Operating Income | ($4.28M) | ($4.71M) | ($3.86M) | ($3.63M) | ($2.74M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.19M | $0.33M | $0.40M | $0.07M | $0.00M |
| Interest Expense | $0.04M | $0.01M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($4.23M) | ($4.39M) | ($3.63M) | ($3.91M) | $4.18M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M |
| Net Income | ($4.23M) | ($4.39M) | ($3.70M) | ($3.91M) | $3.90M |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.50 | $-17.85 | $-18.00 | $-25.65 | $19.80 |
| Wtd Avg Shares | 0.56M | 0.25M | 0.21M | 0.15M | 0.13M |
| EBITDA | ($4.28M) | ($4.38M) | ($3.63M) | ($3.91M) | $4.19M |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Silo Pharma, Inc.
关于Silo Pharma, Inc.（SILO）损益表
Silo Pharma, Inc.（SILO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SILO实现营收$0.00B，毛利润($0.00B)（毛利率-1128.89%），净利润($0.00B)（净利率-5863.50%）。
常见问题
SILO · 4 问Silo Pharma, Inc.（SILO）2025财年营收为$0.00B，同比down0.0%。
SILO revenueSILO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08